Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedMay 24, 2026
DataAggregated Company Financials
Companies50
  • 7D6.4%
  • 3M7.3%
  • 1Y-1.8%
  • YTD-1.7%

In the last week, the Medical Equipment industry is up 6.4%, with Implantica up 33%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 22% per annum.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 25 May 2026SEK 143.2bSEK 73.6bSEK 2.0b35.7x71.7x1.9x
Wed, 22 Apr 2026SEK 140.5bSEK 73.6bSEK 1.8b25.9x76.6x1.9x
Fri, 20 Mar 2026SEK 126.0bSEK 74.5bSEK 1.7b23.8x72.7x1.7x
Sun, 15 Feb 2026SEK 135.1bSEK 76.5bSEK 2.1b29.2x64.9x1.8x
Tue, 13 Jan 2026SEK 149.0bSEK 77.5bSEK 1.9b39.2x77.4x1.9x
Thu, 11 Dec 2025SEK 173.8bSEK 94.0bSEK 2.4b42.3x71.5x1.8x
Sat, 08 Nov 2025SEK 177.1bSEK 94.3bSEK 2.4b45.1x74.7x1.9x
Mon, 06 Oct 2025SEK 179.9bSEK 93.3bSEK 1.4b46.6x129x1.9x
Wed, 03 Sep 2025SEK 182.2bSEK 93.3bSEK 1.4b50.2x132x2x
Fri, 01 Aug 2025SEK 194.8bSEK 93.5bSEK 1.4b53.5x134.5x2.1x
Sun, 29 Jun 2025SEK 191.4bSEK 93.4bSEK 1.5b41.7x128.1x2x
Tue, 27 May 2025SEK 185.8bSEK 93.2bSEK 2.3b34.4x82.3x2x
Thu, 24 Apr 2025SEK 169.7bSEK 92.3bSEK 2.4b30.4x69.6x1.8x
Sat, 22 Mar 2025SEK 160.5bSEK 76.5bSEK 2.5b29.1x64.2x2.1x
Mon, 17 Feb 2025SEK 175.9bSEK 76.3bSEK 2.1b33.2x84x2.3x
Wed, 15 Jan 2025SEK 157.8bSEK 74.7bSEK 1.8b30.1x86.5x2.1x
Fri, 13 Dec 2024SEK 153.6bSEK 74.7bSEK 1.8b27.8x84.3x2.1x
Sun, 10 Nov 2024SEK 161.2bSEK 75.1bSEK 2.0b31.3x82.1x2.1x
Tue, 08 Oct 2024SEK 178.8bSEK 74.5bSEK 3.1b24.3x57.4x2.4x
Thu, 05 Sep 2024SEK 177.0bSEK 74.5bSEK 3.1b26x56.9x2.4x
Sat, 03 Aug 2024SEK 164.6bSEK 74.4bSEK 3.1b26.7x53x2.2x
Mon, 01 Jul 2024SEK 157.3bSEK 72.9bSEK 2.6b30.4x59.9x2.2x
Wed, 29 May 2024SEK 167.8bSEK 73.0bSEK 2.8b30.5x59.9x2.3x
Fri, 26 Apr 2024SEK 196.3bSEK 73.0bSEK 2.5b36.4x78.1x2.7x
Sun, 24 Mar 2024SEK 161.7bSEK 72.2bSEK 2.4b31.9x66.5x2.2x
Tue, 20 Feb 2024SEK 165.5bSEK 71.9bSEK 2.4b42x69.2x2.3x
Thu, 18 Jan 2024SEK 172.5bSEK 71.5bSEK 1.5b40.9x113x2.4x
Sat, 16 Dec 2023SEK 169.6bSEK 71.4bSEK 1.5b39.5x111.1x2.4x
Mon, 13 Nov 2023SEK 155.6bSEK 69.9bSEK 1.3b31.8x116.6x2.2x
Wed, 11 Oct 2023SEK 150.8bSEK 68.7bSEK 1.1b30.1x138.9x2.2x
Fri, 08 Sep 2023SEK 152.8bSEK 68.8bSEK 1.0b30.7x147.7x2.2x
Sun, 06 Aug 2023SEK 163.5bSEK 68.0bSEK 928.4m31.7x176.1x2.4x
Tue, 04 Jul 2023SEK 157.7bSEK 67.0bSEK 1.3b33.8x117.3x2.4x
Thu, 01 Jun 2023SEK 176.2bSEK 66.9bSEK 1.4b36x129.8x2.6x
Price to Earnings Ratio

129.8x


Total Market Cap: SEK 176.2bTotal Earnings: SEK 1.4bTotal Revenue: SEK 66.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 93.8x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 71.7x which is lower than its 3-year average PE of 93.9x.
  • The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 3.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market3.21%
Healthcare3.69%
Medical Equipment6.38%
Medical Equipment8.15%
Medical Supplies-0.87%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 78.6x.
    • Analysts are expecting annual earnings growth of 18.7%, which is higher than its past year's earnings decline of 17.5% per year.
  • Investors are most pessimistic about the Medical Supplies industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings growth rate of 22% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 19% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IMP A SDB ImplanticaSEK 57.5033.1%
+SEK 4.1b		55.4%PS686.5x
EKTA B ElektaSEK 60.609.2%
+SEK 1.9b		23.3%PS1.4x
GETI B GetingeSEK 196.253.8%
+SEK 1.9b		7.2%PE22.7x
SUS Surgical Science SwedenSEK 38.0020.3%
+SEK 327.6m		-73.4%PE37.1x
XVIVO Xvivo PerfusionSEK 294.402.0%
+SEK 182.7m		-2.6%PE125.6x

Latest News

ORT B
SEK 8.47
Ortoma
7D
-2.3%
1Y
-38.2%
EPIS B
SEK 0.17
Episurf Medical
7D
18.5%
1Y
47.9%
SUS
SEK 38.00
Surgical Science Sweden
7D
20.3%
1Y
-73.4%
Analysis Article • May 23

Surgical Science Sweden AB (publ) Just Beat EPS By 21%: Here's What Analysts Think Will Happen Next

The investors in Surgical Science Sweden AB (publ) 's ( STO:SUS ) will be rubbing their hands together with glee today...
IMP A SDB
SEK 57.50
Implantica
7D
33.1%
1Y
55.4%
EKTA B
SEK 60.60
Elekta
7D
9.2%
1Y
23.3%
SIN
SEK 3.53
Solution International Nordics
7D
-4.6%
1Y
n/a
ARJO B
SEK 25.48
Arjo
7D
2.2%
1Y
-11.5%
CEVI
SEK 122.00
CellaVision
7D
-1.0%
1Y
-33.7%
New Narrative • May 14

Digital Cell Analysis And New Applications Will Drive Long Term Upside Potential

Catalysts About CellaVision CellaVision develops digital microscopy solutions that help clinical laboratories automate and standardize blood and bone marrow cell analysis. What are the underlying business or industry changes driving this perspective?
CMOTEC B
SEK 3.37
Scandinavian ChemoTech
7D
-7.2%
1Y
65.2%
XVIVO
SEK 294.40
Xvivo Perfusion
7D
2.0%
1Y
-2.6%
Narrative Update • May 10

XVIVO: Heart Trial Success Will Support Long Term Upside Potential

Analysts have revised their price target for Xvivo Perfusion from SEK 313.40 to SEK 337.00. This reflects updated assumptions on revenue growth, profit margins, discount rate and future P/E multiples.
GETI B
SEK 196.25
Getinge
7D
3.8%
1Y
7.2%
Narrative Update • May 08

GETI B: Higher Dividend And Profitability Assumptions Will Support Future Confidence

Analysts have maintained their SEK 270.0 price target for Getinge, with slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a more refined view of the stock's risk and earnings profile. What's in the News Getinge AB approved a dividend of SEK 4.75 per share at its Annual General Meeting held on April 21, 2026, following the proposal from the Board of Directors and the CEO (Key Developments).
NANEXA
SEK 3.61
Nanexa
7D
-2.0%
1Y
67.9%
VIMIAN
SEK 29.30
Vimian Group
7D
-2.7%
1Y
-24.8%
Narrative Update • May 06

VIMIAN: Margin Execution And Governance Changes Will Support Future Upside Potential

Analysts now see fair value for Vimian Group at about SEK 35, up from roughly SEK 34, even though the latest Street research includes a reduced price target to SEK 25 from SEK 27. This reflects updated views on revenue growth, margins, the appropriate discount rate and future P/E assumptions.
STIL
SEK 249.00
Stille
7D
2.9%
1Y
15.8%
BACTI B
SEK 16.00
Bactiguard Holding
7D
-5.9%
1Y
-54.3%
NOSA
SEK 0.53
Nosa Plugs
7D
-9.3%
1Y
-35.6%